You are here

Article Text

Article menu
Download PDFPDF
Case report
Undifferentiated pleomorphic sarcoma of the chest wall: a rare diagnosis
  1. Swarnita Sahu1,
  2. Shikha Halder1,
  3. Sunila Jain2 and
  4. Rakesh Kumar Koul3
  1. 1Radiation Oncology, BLK Super Speciality Hospital, New Delhi, Delhi, India
  2. 2Pathology, Sir Ganga Ram Hospital, New Delhi, Delhi, India
  3. 3Surgical Oncology, Sir Ganga Ram Hospital, New Delhi, Delhi, India
  1. Correspondence to Dr Swarnita Sahu; swarnitasahu{at}gmail.com

Abstract

A 31-year-old man with no predisposing factors and no history of chronic disease presented with a small painless lump over his anterior chest wall. On evaluation, it was found to be undifferentiated pleomorphic sarcoma. He underwent wide local excision of the tumour with clear margins, followed by adjuvant radiotherapy. At 6-month follow-up, the patient is clinically and radiologically disease free.

  • radiotherapy
  • oncology
  • surgical oncology

https://doi.org/10.1136/bcr-2021-245366

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Twitter @swarnita09

    • Contributors SS is the senior resident (radiation oncology), author of the paper, responsible for drafting the manuscript and revising it. She is the guarantor. SH is the director and the treating senior consultant (radiation oncology) and participated in supervising and revising the manuscript. SJ is the senior consultant (pathology) and contributed by interpreting and drafting the histopathological and the immunohistochemistry images-related portions of the paper. RKK is the treating consultant (surgical oncology) and participated in article editing and oversight.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.